In the pan-cancer analysis of the CRISPR data, we found 104 SL pairs including KEAP1-NFE2L2, RPL22-RPL22L1, RPL22-WRN, APC-CTNNB1, and MTAP-PRMT5 from the DRIVE pan-cancer analysis. This evidence concerns the gene RPL22L1 and cancer.